1.5600 0.00 (0.00%)
After hours: 4:00PM EDT
|Bid||1.5600 x 2200|
|Ask||1.9100 x 3000|
|Day's Range||1.5000 - 1.6000|
|52 Week Range||1.1000 - 1.9900|
|Beta (3Y Monthly)||-0.41|
|PE Ratio (TTM)||N/A|
|Earnings Date||Aug 7, 2017 - Aug 11, 2017|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||2.14|
Company lineup is filling up fast with 50 good names in the microcap markets, as well as some great private and Pre-IPO companies AUSTIN, TX / ACCESSWIRE / September 19, 2019 / The MicroCap Rodeo's inaugural ...
Marrone Bio completed the acquisition of Pro Farm on September 13, 2019, for an agreed enterprise value of $31.8 million, including a combination of $6.2 million cash and 12.7 million shares of Marrone Bio stock paid to Pro Farm’s equity holders, debt holders and advisors in connection with the closing, as well as the opportunity for potential payment of a total of up to $7.5 million of additional shares of stock deliverable from 2021 through 2024 based on the achievement of agreed commercial milestones. As a result of the acquisition, Pro Farm became a wholly owned subsidiary of Marrone Bio.
A sale price for the Citizen You might recall that the Citizen Hotel in downtown Sacramento was sold in July for the first time in four years, to Miami-based private equity firm Cambridge Landmark. What happens now with 301 Capitol Mall Now that the California Public Employees' Retirement System has dropped CIM Group as manager of the 301 Capitol Mall project, the future is uncertain for one of the region's biggest potential commercial developments.
Davis biotechnology company Marrone Bio Innovations Inc. said it paid $2.5 million for two biologic product lines from Jet Harvest Solutions.
Marrone Bio Innovations Inc. (MBII), a leading developer of bio-based products for pest management and plant health, has acquired from Jet Harvest Solutions all rights and assets to the Jet Ag and Jet Oxide product lines. Jet Ag and Jet Oxide are broad-spectrum products used both for control of fungal and bacterial diseases and as disinfectants.
Bee Vectoring Technology, led by local ag-tech executive Ashish Malik, won approval from the U.S. Environmental Protection Agency for its biological fungicide that's delivered to plants by bees.
The cannabis industry has grown in recent months and years, and many companies in the cannabis and health-related industries have been uplisted to reputable U.S. exchanges. Learn about the marijuana stocks on the Nasdaq.
DAVIS, Calif., Aug. 28, 2019 -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, today announced.
DAVIS, Calif., Aug. 28, 2019 -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ: MBII), a leading developer of bio-based products for pest management and plant.
Long term investing is the way to go, but that doesn't mean you should hold every stock forever. It hits us in the gut...
This profile focuses on Marrone Bio Innovations Inc. The company ranked No. 26 on the Business Journal's list this year. See the full list here. Pam Marrone has big plans for her company, Marrone Bio Innovations Inc. “I would really like to be the largest biologicals company on the planet,” she said.
Marrone Bio (MBII) has announced a new financing that allows Marrone to convert existing warrants to equity as long as the stock price is over $1 a share. There are 41.7 million warrants with an exercise price of $1.00. There will be $26.6 million available from warrant conversion of existing warrants if it is needed.
Davis-based Marrone Bio Innovations Inc. said Thursday it is buying Finland-based Pro Farm Technologies for $31.8 million.
Second Quarter 2019 Revenues Rose 22 Percent to $7.0 Million; First Half 2019 Revenues Increased 56 Percent to $15.7 Million Company Also Announces Pro Farm Acquisition to.
Marrone Bio Innovations Inc. (MBII), an international leader in sustainable bioprotection and plant health solutions, announced today that it has entered into a definitive purchase agreement to acquire Pro Farm Technologies OY, which will increase Marrone Bio’s market share and global platform in the $4.6 billion seed- and soil-treatment market. With the acquisition of Pro Farm, Marrone Bio will add proprietary nutrient and biostimulant technology and products for seed and foliar treatments to its portfolio. This transaction also will give the company a significant opportunity to leverage an expanded global distribution network for all of MBI’s products. Marrone Bio expects to benefit from partial-year sales in 2019 as a result of the transaction. With historical gross margins significantly higher than Marrone Bio’s current product portfolio average, the Pro Farm acquisition is expected to be accretive to net income and cash flow from operations in 2020.
Marrone Bio Innovations Inc. (MBII), an international leader in sustainable bioprotection and plant health solutions, announced today that it has established a $36.6 million financing facility with existing investors Ospraie Ag Science LLC, Ardsley Partners Renewable Energy Fund, L.P., and Ivan Saval through a right for Marrone Bio to call the exercise of the investors’ outstanding warrants at $1.00 per share. New warrants to purchase shares at a higher exercise price of $1.75 will be issued on a one-for-one basis along with every called share under the outstanding warrants. The company expects to draw upon the facility only as needed, and may draw on the facility at any time the company’s stock trades above $1.00 per share.
DAVIS, Calif., Aug. 02, 2019 -- Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), a leading developer of bio-based products for pest management and plant health, will release.
Marrone Bio Innovations (MBII) has entered into an agreement with Valagro S.p.A. [Spain] to collaborate on R&D efforts to integrate parts of Marrone's extensive microorganism library with Valagro's biostimulation (enhanced fertilizers) products. This is similar to the recently announced collaboration with Compass Minerals (CMP).
Marrone Bio Innovations Inc. (the “Company” or “MBI”) (MBII), a leading developer of bio-based products for pest management and plant health, today announced that it has entered into a strategic partnership to collaborate on research and development efforts with Valagro S.p.A, a leader in the production and commercialization of biostimulants and specialty nutrients. The global, non-exclusive research collaboration will leverage a subset of Marrone Bio’s collection of 18,000 microorganisms in conjunction with Valagro’s biostimulant and plant nutrition products that enhance crop yield and quality. Products resulting from this partnership have the potential to enhance a grower’s productivity and return on investment with plants that develop better root systems, grow with more vigor and thrive under harsher growing conditions. Additonally, growers of specialty crops would have the potential to produce higher quality fruit that matures more quickly.
Pam Marrone became the CEO of Marrone Bio Innovations, Inc. (NASDAQ:MBII) in 2006. First, this article will compare...
Marrone Bio Innovations Inc. (the “Company” or “MBI”) (MBII), a leading developer of bio-based products for pest management and plant health, today announced that California almond and grape growers are gaining an edge as they address mid-season pest control issues through the implementation of the company’s novel BioUnite program. Marrone Bio launched BioUnite to provide growers with integrated pest management programs that harness the power of biology with the performance of chemistry resulting in a more efficient food production system that is affordable, sustainable, safe, and easy to use.
By Ian Gilson, PhD, CFA NASDAQ:MBII READ THE FULL MBII RESEARCH REPORT On June 25, 2019, Marrone Bio Innovations (NASDAQ:MBII) received notice that the major claims covering composition and method of manufacture ...
Marrone Bio Innovations Inc. (MBII) (MBI), a leading developer of biological crop protection and plant health solutions, has received a notice of allowance from the U.S. Patent and Trademark Office for key claims covering the composition and method of manufacturing for Grandevo WDG, an MBI developed microbial-based bioinsecticide. A Notice of Allowance is a document sent to a patent applicant from the United States Patent and Trademark Office after a patent examiner has decided to issue the requested patent.
Marrone Bio Innovations has released the results of a 2018 study on the impact of Venerate® XC and Grandevo® WDG on almond pests. The addition of Venerate® XC reduced the total nut damage due to navel orangeworm, Amyelois transitella, by an additional two percent. This pest has developed a resistance to a number of conventional chemical pesticides.